Table 5 Treatments of patients infected with COVID-19
Total (n = 156) | Survivor (n = 100) | Non-survivor (n = 56) | P valuea | |
|---|---|---|---|---|
Antibiotics, % | 150 (96.2) | 96 (96.0) | 54 (96.4) | 1.000 |
Antiviral treatment, % | 139 (89.1) | 89 (89.0) | 50 (89.3) | 0.956 |
Corticosteroids, % | 60 (38.5) | 22 (22.0) | 38 (67.9) | < 0.001 |
Intravenous immunoglobulin, % | 51 (32.7) | 18 (18.0) | 33 (58.9) | < 0.001 |
High-flow nasal cannula oxygen therapy, % | 56 (35.9) | 26 (26.0) | 30 (53.6) | 0.001 |
Non-invasive mechanical ventilation, % | 44 (28.2) | 13 (13.0) | 31 (55.4) | < 0.001 |
Invasive mechanical ventilation, % | 19 (12.2) | 1 (1.0) | 18 (32.1) | < 0.001 |
RRT, % | 6 (3.8) | 1 (1.0) | 5 (8.9) | 0.023 |